BrightView (BV): Buy, Sell, or Hold Post Q4 Earnings?

StockStory
03-28
BrightView (BV): Buy, Sell, or Hold Post Q4 Earnings?

Although the S&P 500 is down 1.4% over the past six months, BrightView’s stock price has fallen further to $13.27, losing shareholders 15.7% of their capital. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Is there a buying opportunity in BrightView, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free.

Even with the cheaper entry price, we're sitting this one out for now. Here are three reasons why we avoid BV and a stock we'd rather own.

Why Do We Think BrightView Will Underperform?

An official field consultant for Major League Baseball, BrightView (NYSE:BV) offers landscaping design, development, and maintenance.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can have short-term success, but a top-tier one grows for years. Over the last five years, BrightView grew its sales at a sluggish 2.3% compounded annual growth rate. This was below our standards.

2. EPS Trending Down

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Sadly for BrightView, its EPS declined by 6.5% annually over the last five years while its revenue grew by 2.3%. This tells us the company became less profitable on a per-share basis as it expanded.

3. Previous Growth Initiatives Haven’t Impressed

Growth gives us insight into a company’s long-term potential, but how capital-efficient was that growth? A company’s ROIC explains this by showing how much operating profit it makes compared to the money it has raised (debt and equity).

BrightView historically did a mediocre job investing in profitable growth initiatives. Its five-year average ROIC was 2%, lower than the typical cost of capital (how much it costs to raise money) for industrials companies.

Final Judgment

BrightView falls short of our quality standards. After the recent drawdown, the stock trades at 14.9× forward price-to-earnings (or $13.27 per share). While this valuation is reasonable, we don’t see a big opportunity at the moment. There are better investments elsewhere. We’d suggest looking at one of our top software and edge computing picks.

Stocks We Would Buy Instead of BrightView

The elections are now behind us. With rates dropping and inflation cooling, many analysts expect a breakout market - and we’re zeroing in on the stocks that could benefit immensely.

Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.

Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10